Total Payments
$9,618
2024 Payments
$962.10
Companies
62
Transactions
602
Medicare Patients
28,348
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$8,787 (91.4%)
Consulting$800.00 (8.3%)
Education$31.30 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,787 | 596 | 91.4% |
| Consulting Fee | $800.00 | 1 | 8.3% |
| Education | $31.30 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,029 | 69 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $800.00 | 1 | $0 (2021) |
| Novo Nordisk Inc | $794.79 | 49 | $0 (2024) |
| Lilly USA, LLC | $775.77 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $679.88 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $601.70 | 53 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $597.77 | 35 | $0 (2023) |
| PFIZER INC. | $392.38 | 37 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $350.04 | 23 | $0 (2023) |
| Merck Sharp & Dohme LLC | $332.44 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $962.10 | 52 | AstraZeneca Pharmaceuticals LP ($156.07) |
| 2023 | $885.16 | 50 | GlaxoSmithKline, LLC. ($150.29) |
| 2022 | $167.59 | 9 | AstraZeneca Pharmaceuticals LP ($39.24) |
| 2021 | $1,479 | 45 | Paratek Pharmaceuticals, Inc. ($800.00) |
| 2020 | $1,135 | 72 | Novo Nordisk Inc ($278.13) |
| 2019 | $1,413 | 106 | Lilly USA, LLC ($173.73) |
| 2018 | $1,530 | 118 | AstraZeneca Pharmaceuticals LP ($203.59) |
| 2017 | $2,046 | 150 | AstraZeneca Pharmaceuticals LP ($283.55) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.96 | General |
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/28/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Hematology | ||||||
| 08/21/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Vaccines | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.32 | General |
| 07/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/20/2024 | Abbott Laboratories | FREESTYLE INSULINX (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes Care | ||||||
| 06/20/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes Care | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 5,435 | 10,474 | $612,959 | $332,388 |
| 2022 | 44 | 6,439 | 12,281 | $697,890 | $366,890 |
| 2021 | 48 | 7,613 | 14,618 | $861,174 | $457,043 |
| 2020 | 55 | 8,861 | 17,017 | $982,864 | $536,485 |
Total Patients
28,348
Total Services
54,390
Medicare Billing
$1.7M
Procedure Codes
188
All Medicare Procedures & Services
188 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 369 | 1,629 | $162,814 | $88,931 | 54.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 202 | 1,246 | $80,990 | $53,883 | 66.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 613 | $88,885 | $45,912 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 303 | 303 | $53,025 | $35,533 | 67.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 277 | 278 | $25,020 | $20,717 | 82.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 36 | 45 | $12,375 | $8,387 | 67.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 147 | 599 | $14,975 | $7,364 | 49.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 187 | 190 | $13,450 | $6,330 | 47.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 277 | 294 | $17,640 | $5,968 | 33.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 316 | 316 | $6,320 | $5,150 | 81.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 313 | 313 | $6,260 | $5,101 | 81.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 154 | 554 | $16,620 | $4,973 | 29.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 88 | $11,000 | $4,873 | 44.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 28 | $5,600 | $4,074 | 72.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 359 | 666 | $3,996 | $3,899 | 97.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 187 | 191 | $3,870 | $3,732 | 96.4% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 25 | 26 | $5,200 | $3,634 | 69.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 161 | 778 | $11,670 | $2,953 | 25.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 316 | 373 | $7,460 | $2,817 | 37.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 281 | 291 | $17,460 | $2,507 | 14.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 129 | 276 | $5,520 | $2,271 | 41.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 25 | 38 | $5,700 | $1,929 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,060 | $1,677 | 54.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $1,815 | $1,512 | 83.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 42 | 42 | $4,200 | $1,360 | 32.4% |
About Dr. Mukesh Jain, MD
Dr. Mukesh Jain, MD is a Specialist healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447282991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mukesh Jain, MD has received a total of $9,618 in payments from pharmaceutical and medical device companies, with $962.10 received in 2024. These payments were reported across 602 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($8,787).
As a Medicare-enrolled provider, Jain has provided services to 28,348 Medicare beneficiaries, totaling 54,390 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 188 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Specialist, Hospitalist
- Location Southaven, MS
- Active Since 07/07/2006
- Last Updated 11/20/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447282991
Products in Payments
- NUZYRA (Drug) $800.00
- Ozempic (Drug) $531.73
- XARELTO (Drug) $512.88
- JARDIANCE (Drug) $403.52
- FARXIGA (Drug) $330.36
- TRELEGY ELLIPTA (Drug) $317.69
- TRULICITY (Drug) $263.03
- BEVESPI AEROSPHERE (Drug) $241.31
- MOUNJARO (Drug) $223.08
- JANUVIA (Drug) $205.89
- CHANTIX (Drug) $186.83
- ELIQUIS (Drug) $159.62
- ENTRESTO (Drug) $152.79
- Myrbetriq (Drug) $150.94
- TOUJEO (Drug) $130.03
- FREESTYLE LIBRE (Device) $126.17
- SYMBICORT (Drug) $125.89
- BRILINTA (Drug) $123.50
- GEMTESA (Drug) $123.37
- ANORO (Drug) $121.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Southaven
Ulric Duncan, M.d, M.D
Specialist — Payments: $20,664
Specialist $20,664
David Spence, Md, MD
Specialist — Payments: $4,773
Specialist $4,773
Hai Dang, M.d, M.D
Specialist
Specialist
Angela Pauly, Otr, OTR
Specialist
Specialist
Miss. Natalie Cathcart, M.s. Otr L, M.S. OTR L
Specialist
Specialist
Ma Tessa Layugan, M.d, M.D
Specialist
Specialist